← All organizations
Highest phase reached
Phase 1
First clinical trial
Nov 30, 2017Last known activity
Dec 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (4 distinct, 3 trials)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (8)
- NCT06362889Lead sponsorPhase 1Dec 31, 2025
- NCT06362889OfficialPhase 1Dec 31, 2025
- NCT03555357Reponsible party - principal investigatorN/AJul 31, 2018
- NCT03555357Overall official - principal investigatorN/AJul 31, 2018
- NCT03555357Lead sponsorN/AJul 31, 2018
- NCT03313934Reponsible party - principal investigatorEarly Phase 1Nov 30, 2017
- NCT03313934Overall official - principal investigatorEarly Phase 1Nov 30, 2017
- NCT03313934Lead sponsorEarly Phase 1Nov 30, 2017
Details
- Last known activity
- Dec 31, 2025